NCTY Q1 2012 Earnings Narrower Loss Beats Estimates as Company Restructures RILYN Q1 2024 Earnings Significant Loss Reported Revenue Not Disclosed UroGen Pharma Ltd URGN Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction MLYS Q1 2026 Earnings Narrow Beat on Losses as Clinical Pipeline Progress Continues GPI Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick GLBS Q4 2025 Earnings Strong EPS Surprise Driven by Operational Efficiency FORTY Q1 2025 Earnings EPS of 123 Reported Amid Stock Decline CMSC Q1 2026 Earnings EPS Beats Estimates Modest Stock Uptick PAGP Q1 2026 Earnings Strong EPS Surprise of 11972 Beats Estimates FNB Q1 2026 Earnings Narrow EPS Miss Offset by Resilient Operations IAC Q1 2026 Earnings Deep EPS Miss but Stock Gains Amid Operational Adjustments FRSX Q3 2021 Earnings NarrowerThanExpected Loss Drives Positive Market Response